| 摘要 |
<p>This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers. tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.</p> |
| 申请人 |
XENON PHARMACEUTICALS INC. |
发明人 |
CHAFEEV, MIKHAIL;CHOWDHURY, SULTAN;FRASER, LAUREN;FU, JIANMIN;LANGILLE, JONATHAN;LIU, SHIFENG;SUN, JIANYU;SUN, SHAOYI;SVIRIDOV, SERGUEI;WOOD, MARK;ZENOVA, ALLA;JIA, QI;CADIEUX, JEAN-JACQUES;GAUTHIER, SIMON J.;DOUGLAS, AMY FRANCES;HSIEH, TOM;CHAKKA, NAGASREE;CIKOJEVIC, ZORAN |
